BNTC
Benitec Biopharma Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website benitec.com
- Employees(FY) 18
- ISIN US08205P2092
Performance
+3.38%
1W
+98.54%
1M
+218.56%
3M
+164.35%
6M
+193.81%
YTD
+193.81%
1Y
Profile
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.
Technical Analysis of BNTC 2024-05-10
Overview:
In analyzing the technical indicators for BNTC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-13 02:53
- 2024-05-12 20:15
- 2024-04-30 20:00
- 2024-04-17 19:30
- 2024-04-17 19:00
- 2024-04-08 20:00
- 2024-03-23 19:55
11 Best ASX Stocks To Buy Now(Insidermonkey)
- 2024-02-12 19:00
- 2023-11-29 18:00
- 2023-11-16 19:00
- 2023-11-12 19:00
- 2023-09-20 20:00
- 2023-08-21 09:02
- 2023-08-18 09:02
- 2023-08-11 01:00
- 2023-08-08 10:30
- 2023-07-25 01:00
- 2023-06-25 20:00
- 2023-05-14 20:00
- 2023-05-07 20:05
- 2023-05-07 20:00
- 2023-02-12 19:00
- 2023-01-22 20:48
- 2022-11-09 19:00
- 2022-09-15 20:42
- 2022-09-12 10:06
- 2022-09-01 20:00
- 2022-07-14 18:52
- 2022-05-15 20:15
Benitec Biopharma Releases Q3 2022 Financial Results(Yahoo Finance)
- 2022-02-13 19:00
Benitec Biopharma Discloses Q2 2022 Financial Results(Yahoo Finance)
Page 1 of 4
previousnext